Cargando…
Challenging the standard of care in advanced melanoma: focus on pembrolizumab
The last several years have seen a dramatic rise in the number of effective therapies that have been shown to improve survival outcomes for patients with advanced melanoma. Among these treatments are the immune checkpoint inhibitors, a new class of immunotherapy, that have demonstrated the ability t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626384/ https://www.ncbi.nlm.nih.gov/pubmed/29026335 http://dx.doi.org/10.2147/CMAR.S92546 |